N,N-Bis(2-chloroethyl)aniline hydrochloride

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 530280

CAS#: 6150-64-7

Description: N,N-Bis(2-chloroethyl)aniline hydrochloride is a bioactive chemical.

Chemical Structure

img
N,N-Bis(2-chloroethyl)aniline hydrochloride
CAS# 6150-64-7
Instruction

Theoretical Analysis

MedKoo Cat#: 530280
Name: N,N-Bis(2-chloroethyl)aniline hydrochloride
CAS#: 6150-64-7
Chemical Formula: C10H14Cl3N
Exact Mass: 253.02
Molecular Weight: 254.579
Elemental Analysis: C, 47.18; H, 5.54; Cl, 41.77; N, 5.50

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: N,N-Bis(2-chloroethyl)aniline hydrochloride

IUPAC/Chemical Name: Aniline, N,N-bis(2-chloroethyl)-, hydrochloride

InChi Key:

InChi Code:

SMILES Code:

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 254.58 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Marvania B, Kakadiya R, Christian W, Chen TL, Wu MH, Suman S, Tala K, Lee TC, Shah A, Su TL. The synthesis and biological evaluation of new DNA-directed alkylating agents, phenyl N-mustard-4-anilinoquinoline conjugates containing a urea linker. Eur J Med Chem. 2014 Aug 18;83:695-708. doi: 10.1016/j.ejmech.2014.06.066. Epub 2014 Jun 28. PubMed PMID: 25014640.

2: Papageorgiou A, Lialiaris T, Stergiou E, Stergiou I, Tsigris C, Kourti A, Geromichalos G, Stravoravdi P, Trafalis D, Athanassiou AE, Pitsas A, Camoutsis Ch. Preclinical studies of steroid-linked nitrosoureas in murine pancreatic adenocarcinoma PANO2. J BUON. 2008 Apr-Jun;13(2):235-9. PubMed PMID: 18555471.

3: Marquis JC, Hillier SM, Dinaut AN, Rodrigues D, Mitra K, Essigmann JM, Croy RG. Disruption of gene expression and induction of apoptosis in prostate cancer cells by a DNA-damaging agent tethered to an androgen receptor ligand. Chem Biol. 2005 Jul;12(7):779-87. PubMed PMID: 16039525.

4: Trafalis DT, Tsavdaridis D, Camoutsis C, Karayiani V, Mourelatos D, Dalezis P, Athanassiou A, Pangalis GA, Papageorgiou A. Preclinical studies on NSC290205 aza-steroid alkylator activity in combination with adriamycin against lymphoid leukaemia. Br J Haematol. 2005 Feb;128(3):343-50. PubMed PMID: 15667536.

5: Sharma U, Marquis JC, Nicole Dinaut A, Hillier SM, Fedeles B, Rye PT, Essigmann JM, Croy RG. Design, synthesis, and evaluation of estradiol-linked genotoxicants as anti-cancer agents. Bioorg Med Chem Lett. 2004 Jul 16;14(14):3829-33. PubMed PMID: 15203171; PubMed Central PMCID: PMC4096836.

6: Kestell P, Pruijn FB, Siim BG, Palmer BD, Wilson WR. Pharmacokinetics and metabolism of the nitrogen mustard bioreductive drug 5. Cancer Chemother Pharmacol. 2000;46(5):365-74. PubMed PMID: 11127940.

7: Khan TH, Eno-Amooquaye EA, Searle F, Browne PJ, Osborn HM, Burke PJ. Novel inhibitors of carboxypeptidase G2 (CPG2): potential use in antibody-directed enzyme prodrug therapy. J Med Chem. 1999 Mar 25;42(6):951-6. PubMed PMID: 10090777.

8: Choi BG, Kim OY, Chung BH, Cho WJ, Cheon SH, Choi SU, Lee CO. Synthesis of antineoplaston A10 analogs as potential antitumor agents. Arch Pharm Res. 1998 Apr;21(2):157-63. PubMed PMID: 9875424.

9: Lee HH, Palmer BD, Wilson WR, Denny WA. Synthesis and hypoxia-selective cytotoxicity of a 2-nitroimidazole mustard. Bioorg Med Chem Lett. 1998 Jul 7;8(13):1741-4. PubMed PMID: 9873426.

10: Gamcsik MP, Millis KK, Hamill TG. Kinetics of the conjugation of aniline mustards with glutathione and thiosulfate. Chem Biol Interact. 1997 Jun 6;105(1):35-52. PubMed PMID: 9233374.

11: Palmer BD, Wilson WR, Anderson RF, Boyd M, Denny WA. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide. J Med Chem. 1996 Jun 21;39(13):2518-28. PubMed PMID: 8691449.

12: Wentworth P, Datta A, Blakey D, Boyle T, Partridge LJ, Blackburn GM. Toward antibody-directed "abzyme" prodrug therapy, ADAPT: carbamate prodrug activation by a catalytic antibody and its in vitro application to human tumor cell killing. Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):799-803. PubMed PMID: 8570638; PubMed Central PMCID: PMC40136.

13: Blakey DC, Davies DH, Dowell RI, East SJ, Burke PJ, Sharma SK, Springer CJ, Mauger AB, Melton RG. Anti-tumour effects of an antibody-carboxypeptidase G2 conjugate in combination with phenol mustard prodrugs. Br J Cancer. 1995 Nov;72(5):1083-8. PubMed PMID: 7577451; PubMed Central PMCID: PMC2033956.

14: Palmer BD, van Zijl P, Denny WA, Wilson WR. Reductive chemistry of the novel hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide. J Med Chem. 1995 Mar 31;38(7):1229-41. PubMed PMID: 7707325.

15: Palmer BD, Wilson WR, Atwell GJ, Schultz D, Xu XZ, Denny WA. Hypoxia-selective antitumor agents. 9. Structure-activity relationships for hypoxia-selective cytotoxicity among analogues of 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide. J Med Chem. 1994 Jul 8;37(14):2175-84. PubMed PMID: 8035424.

16: Catsoulacos P, Catsoulacos D. Antitumor activity of homo-aza-steroidal esters of p-N, N-bis(2-chloroethyl)aminophenoxyacetic acid. Anticancer Res. 1993 Jul-Aug;13(4):1203-8. PubMed PMID: 8352545.

17: Voutsinas G, Kappas A, Demopoulos NA, Catsoulacos P. Comparative study on the mutagenicity of three structurally related substituted aniline mustards in the Salmonella/microsome assay. Mutat Res. 1993 Feb;298(4):261-7. PubMed PMID: 7678162.

18: Palmer BD, Wilson WR, Cliffe S, Denny WA. Hypoxia-selective antitumor agents. 5. Synthesis of water-soluble nitroaniline mustards with selective cytotoxicity for hypoxic mammalian cells. J Med Chem. 1992 Aug 21;35(17):3214-22. PubMed PMID: 1507207.

19: Wallace PM, Senter PD. In vitro and in vivo activities of monoclonal antibody-alkaline phosphatase conjugates in combination with phenol mustard phosphate. Bioconjug Chem. 1991 Sep-Oct;2(5):349-52. PubMed PMID: 1790175.

20: Catsoulacos P, Catsoulacos D. Hybrid anticancer compounds. Steroidal lactam esters of carboxylic derivatives of N,N-bis (2-chloroethyl) aniline (review). Anticancer Res. 1991 Sep-Oct;11(5):1773-7. Review. PubMed PMID: 1768051.